Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

$Case Study: Mechanism and Treatment of Refractory ISR$

Presentation TCT 2018

Case Study: Mechanism and Treatment of Refractory ISR

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

$Role of Brachytherapy for Refractory ISR in 2018$

Presentation TCT 2018

Role of Brachytherapy for Refractory ISR in 2018

Presenter: Fernando Alfonso, Azeem Latib, Ron Waksman

September 22, 2018

Presentation TCT 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Presenter: Fernando Alfonso, Azeem Latib, Juan F. Granada

September 22, 2018

Presentation TCT 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presenter: Fernando Alfonso, Azeem Latib, Bruno Scheller

September 22, 2018

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

Presentation TCT 2017

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

Presenter: Corrado Tamburino, Robert-Jan van Geuns, Joanna J. Wykrzykowska

November 01, 2017

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Good Long-term Results With FANTOM BVS, but More Data Needed

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Case Study: Mechanism and Treatment of Refractory ISR

Role of Brachytherapy for Refractory ISR in 2018

Next Generation Drug-Coated Balloons: Limus and Beyond

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Case Study: Mechanism and Treatment of Stent Thrombosis

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content